Top Stories

What to know before key FDA panel vote


Vials of Johnson & Johnson’s Janssen coronavirus disease (COVID-19) vaccine candidate are seen during the Phase 3 ENSEMBLE trial in an undated photograph.

Johnson & Johnson | via Reuters

A key Food and Drug Administration advisory panel is scheduled to vote Friday on whether to recommend approval of Johnson & Johnson‘s Covid-19 vaccine for emergency use, which would help pave the way to distribute a third preventive treatment in the U.S.

A favorable vote from the Vaccines and Related Biological Products Advisory Committee will likely clear the path for the U.S. agency to approve J&J’s vaccine for emergency use. The committee plays a central role in approving vaccines in the U.S., verifying…


Weekly jobless claims drop sharply but labor market remains challenged

Previous article

Coinbase files for direct listing after revenue more than doubles in 2020

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories